(Total Views: 319)
Posted On: 07/30/2021 10:13:15 AM
Post# of 36564
I'll add one other thing, well three..
If the US goes back on lockdown due to the Delta Variant, that is going to probably once again, put on the backburner the Excellegan sales to the VA I would think. Please correct me if I am wrong here. So, that part is going to suffer for Generex and should not be a surprise. That is another reason we need the IND and the trials now.
The Arizona, Florida and Ohio. With things happening, these could increase revenue with a lockdown, due to video calls, etc.. So, picking up more patients.
Overseas, I would expect the China entity to now go full swing into the China FDA approval happening and trials there starting?
If the US goes back on lockdown due to the Delta Variant, that is going to probably once again, put on the backburner the Excellegan sales to the VA I would think. Please correct me if I am wrong here. So, that part is going to suffer for Generex and should not be a surprise. That is another reason we need the IND and the trials now.
The Arizona, Florida and Ohio. With things happening, these could increase revenue with a lockdown, due to video calls, etc.. So, picking up more patients.
Overseas, I would expect the China entity to now go full swing into the China FDA approval happening and trials there starting?
(0)
(0)
